The Securities and Exchange Commission has not necessarily reviewed the information in this filing and has not determined if it is accurate and complete. | |||||||||||||||||||||
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 13F FORM 13F INFORMATION TABLE |
|
COLUMN 1 | COLUMN 2 | COLUMN 3 | COLUMN 4 | COLUMN 5 | COLUMN 6 | COLUMN 7 | COLUMN 8 | ||||
VALUE | SHRS OR | SH/ | PUT/ | INVESTMENT | OTHER | VOTING AUTHORITY | |||||
NAME OF ISSUER | TITLE OF CLASS | CUSIP | (x$1000) | PRN AMT | PRN | CALL | DISCRETION | MANAGER | SOLE | SHARED | NONE |
ABEONA THERAPEUTICS-NEW | COM NEW | 00289Y206 | 7,420,000 | 1,750,000 | SH | SOLE | 1,750,000 | 0 | 0 | ||
ABIVAX SA | SPONSORED ADS | 00370M103 | 5,002,659 | 378,416 | SH | SOLE | 378,416 | 0 | 0 | ||
BEYOND AIR INC | COM | 08862L103 | 485,511 | 903,614 | SH | SOLE | 903,614 | 0 | 0 | ||
BIOFRONTERA INC | COM NEW | 09077D209 | 452,826 | 504,261 | SH | SOLE | 504,261 | 0 | 0 | ||
BIOXCEL THERAPEUTICS INC | COM | 09075P105 | 50,780 | 39,672 | SH | SOLE | 39,672 | 0 | 0 | ||
CELLECTAR BIOSCIENCES INC | COM NEW | 15117F807 | 6,764,040 | 2,705,616 | SH | SOLE | 2,098,185 | 0 | 0 | ||
COMPASS PATHWAYS PLC | SPONSORED ADS | 20451W101 | 4,433,360 | 734,000 | SH | SOLE | 734,000 | 0 | 0 | ||
CLEARSIDE BIOMEDICAL INC | COM | 185063104 | 3,370,371 | 2,592,593 | SH | SOLE | 2,592,593 | 0 | 0 | ||
CYBIN INC | COM | 23256X100 | 5,230,300 | 19,300,000 | SH | SOLE | 19,300,000 | 0 | 0 | ||
DELCATH SYSTEMS, INC. | COM NEW | 24661P807 | 15,528,629 | 2,650,389 | SH | SOLE | 2,650,389 | 0 | 0 | ||
FORTRESS BIOTECH INC-NEW | COM NEW | 34960Q307 | 1,039,333 | 607,797 | SH | SOLE | 607,797 | 0 | 0 | ||
GERON CORP | COM | 374163103 | 848,000 | 200,000 | SH | SOLE | 200,000 | 0 | 0 | ||
INSPIREMD INC | COM | 45779A846 | 6,272,288 | 2,513,641 | SH | SOLE | 2,513,641 | 0 | 0 | ||
JOURNEY MEDICAL CORP | COM | 48115J109 | 643,704 | 114,132 | SH | SOLE | 114,132 | 0 | 0 | ||
KALVISTA PHARMACEUTICALS INC | COM | 483497103 | 3,981,463 | 337,985 | SH | SOLE | 337,985 | 0 | 0 | ||
KIORA PHARMACEUTICALS INC | COM NEW | 49721T309 | 1,073,331 | 255,555 | SH | SOLE | 255,555 | 0 | 0 | ||
LYRA THERAPEUTICS INC | COM | 55234L105 | 286,321 | 1,034,773 | SH | SOLE | 1,034,773 | 0 | 0 | ||
MEDIWOUND LTD | SHS NEW | M68830112 | 7,969,365 | 513,490 | SH | SOLE | 513,490 | 0 | 0 | ||
MYOMO INC | COM NEW | 62857J201 | 8,554,647 | 2,664,999 | SH | SOLE | 2,664,999 | 0 | 0 | ||
NEWAMSTERDAM PHARMA CO NV | ORDINARY SHARES | N62509109 | 194,463 | 10,123 | SH | SOLE | 10,123 | 0 | 0 | ||
Ocular Therapeutix, Inc | COM | 67576A100 | 5,130,000 | 750,000 | SH | SOLE | 750,000 | 0 | 0 | ||
OPTINOSE INC | COM | 68404V100 | 7,849,034 | 7,547,148 | SH | SOLE | 7,547,148 | 0 | 0 | ||
OUTLOOK THERAPEUTICS INC | COM NEW | 69012T206 | 3,321,000 | 450,000 | SH | SOLE | 450,000 | 0 | 0 | ||
POLYPID LTD | COM | M8001Q126 | 1,792,240 | 416,800 | SH | SOLE | 416,800 | 0 | 0 | ||
PROFOUND MEDICAL CORP | COM NEW | 74319B502 | 4,474,664 | 533,333 | SH | SOLE | 533,333 | 0 | 0 | ||
REZOLUTE INC | COM NEW | 76200L309 | 1,075,000 | 250,000 | SH | SOLE | 250,000 | 0 | 0 | ||
SPRUCE BIOSCIENCES INC | COM | 85209E109 | 780,908 | 1,508,419 | SH | SOLE | 1,508,419 | 0 | 0 | ||
TALPHERA INC | COM NEW | 00444T209 | 675,480 | 758,966 | SH | SOLE | 758,966 | 0 | 0 | ||
TONIX PHARMA HLDG CRP | COM NEW | 890260854 | 19,635 | 28,154 | SH | SOLE | 28,154 | 0 | 0 | ||
TREVI THERAPEUTICS INC | COM | 89532M101 | 4,146,899 | 1,391,577 | SH | SOLE | 1,391,577 | 0 | 0 | ||
UNICYCIVE THERAPEUTICS INC | COM | 90466Y103 | 787,328 | 1,571,200 | SH | SOLE | 1,571,200 | 0 | 0 | ||
VERONA PHARMA PLC | SPONSORED ADS | 925050106 | 3,615,000 | 250,000 | SH | SOLE | 250,000 | 0 | 0 | ||
VERU INC | COM | 92536C103 | 2,268,147 | 2,696,003 | SH | SOLE | 2,696,003 | 0 | 0 | ||
VIRIDIAN THERAPEUTICS INC | COM | 92790C104 | 3,903,000 | 300,000 | SH | SOLE | 300,000 | 0 | 0 | ||
XERIS BIOPHARMA HLDGS INC | COM | 98422E103 | 7,020,382 | 3,120,170 | SH | SOLE | 3,120,170 | 0 | 0 | ||
SPDR SER TR | S&P BIOTECH | 78464A870 | 1,044,338 | 22,403 | SH | Put | SOLE | 2,240,300 | 0 | 0 | |
ALNYLAM PHARMACEUTICALS INC | PUT | 02043Q957 | 0 | 700 | SH | Put | SOLE | 70,000 | 0 | 0 | |
ANNOVIS BIO INC | PUT | 03615A958 | 839,175 | 24,154 | SH | Put | SOLE | 2,415,400 | 0 | 0 | |
G1 THERAPEUTICS INC | PUT | 3621LQ959 | 304,815 | 19,018 | SH | Put | SOLE | 1,901,800 | 0 | 0 | |
CASSAVA SCIENCES INC | PUT | 14817C957 | 1,304,460 | 3,673 | SH | Put | SOLE | 367,300 | 0 | 0 |